Search results
Can Neosporin in the Nose Help Prevent Viral Infections?
Time Magazine· 2 days agoFor years, researchers have been working on vaccines that aim to prevent viral infections by...
Bill Maher Batters His Buddy RFK Jr. Over Anti-Vax Claims
The Daily Beast· 1 day agoBill Maher took presidential candidate Robert F. Kennedy Jr. to task on Friday’s episode of Real...
Dr. Anthony Fauci to testify before House COVID-19 panel for first time since retirement
New York Post· 4 days agoHis answers related to social distancing guidelines and vaccine mandates imposed on Americans during...
Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National...
Digital Journal· 6 days ago(NASDAQ:MRNA) today announced a contract with the Ministry of Health in Brazil (Ministério da Saúde) to supply its mRNA COVID-19 vaccine
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 5 days agoThe pair won the 2023 Nobel Prize in Medicine for discoveries that were “critical for developing...
How mRNA Is Rewriting the Rules of Cancer Treatment
SciTechDaily· 4 days agoMIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful...
...Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 5 days agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Canada injects $36M into federal vaccine injury compensation fund
Houston Today· 4 days agoThe federal government has added $36.4 million to a program designed to support people who have been...
Maine high court says EMS Board had authority to impose vaccine mandate
Bangor Daily News· 2 days agoMaine’s highest court has ruled a state board overseeing emergency medical service workers had the...
The Motley Fool: Pfizer offers a pfat 6.4% dividend
Dallas Morning News· 10 hours agoShares of Pfizer were recently down more than 35% over the past year — in part because the market’s enthusiasm for its COVID-19 vaccine